Innovation & TechnologyInvestments

BrainVision Center to be established in Budapest

The new research center will be led by Professor Botond Roska and Balázs Rózsa, with the support of the Ministry of Innovation and Technology.

As MTI reported, the BrainVision Center will be responsible for the preparation of basic research processes for the diagnosis and therapy of central nervous system diseases and the implementation of a basic research program for vision restoration. The center will also provide the opportunity to develop optical systems based on the interaction of light and the brain.

Minister of Innovation and Technology László Palkovics said that the government has put in place the legislative and institutional framework and is also in the process of restructuring higher education institutions. However, innovation results need to be placed in an international context, he said, adding that to this end, the government has examined which research areas are of international relevance. 

The minister stressed that Botond Roska’s research falls into this category. 

Botond Roska, head of the Institute of Molecular and Clinical Ophthalmology in Basel and a visiting professor at Semmelweis University, works in Switzerland on restoring sight. Roska has said that his procedure has been successfully applied to five patients so far, but there is still a long way to go before more people could be involved in the therapy. 

Rózsa said that the work at the BrainVision Center, using new molecular biology methodologies and 3D laser microscopy technology, will not only allow them to investigate the effectiveness of vision restoration therapies but will also provide optogenetic answers to a number of diseases of the central nervous system, such as depression, dementia and epilepsy.

He added that the center plans to use a so-called “all-in-one” microscope technique, which combines all the advantages of two-dimensional and three-dimensional techniques in a single device. The new technique will allow cell types in the brain, labeled by different genetic methods, to be examined in motion. With this technique, they can test the effectiveness of different genetic therapies in restoring retinal function, he stressed.

Several professionals will collaborate on the project, resulting in one of the world’s most important human translational centers. The project is currently in the preparatory phase and is expected to start operations in December.

Show More

Related Articles

Back to top button